Buy Crypto Markets Spot FuturesZEC Earn Event Centre Rewards Hub

Gain Therapeutics, Inc. (GANX)

NASDAQ

$1.83

$+0.05

(+2.78%)

Previous Close: ⁦$1.80⁩

Market Closed

Gain Therapeutics, Inc. (GANX) Live Price Chart

Last updated: ⁦2026-09-09 02:47:40⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

Gain Therapeutics, Inc. (GANX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1.83, with a market capitalisation of $78.56M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.53 to $4.34. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$78.56M
Open	$1.80
Day's High	$17.93
Day's Low	$0.89
Previous Close	$1.80
Volume	287.32K
Average Volume	790.69K
P/E Ratio	--
52-Week High	$4.34
52-Week Low	$1.53
Dividend Yield	--
Earnings Date	--

Gain Therapeutics, Inc. (GANX) Latest Closing Stock Price

Gain Therapeutics, Inc. (GANX) last closed at $1.80 as of 2026-09-08 23:31:00, unchanged from the previous close of $1.80.

During the latest regular trading session, GANX traded between $0.89 and $17.93, with a volume of 287.32K shares. The closing price was near the lower end and near the lower end of its 52-week range.

Gain Therapeutics, Inc. (GANX) 7-Day Stock Price Change

Over the past seven days, Gain Therapeutics, Inc. (GANX) moved from $1.85 to $1.83, representing a decline of 1.35% ($0.03).

The stock traded between $1.75 and $1.90 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.

The average daily volume was 307.27 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

GANX 52-Week Price Position

Position in Range: 10.5%

52W Low$1.53

52W High$4.34

GANX is currently trading at $1.83, placing it 10.5% of the way from its 52-week low of $1.53 to its 52-week high of $4.34. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Gain Therapeutics, Inc. (GANX)?

Gain Therapeutics Inc is a clinical-stage biotechnology company developing novel small-molecule therapeutics to treat diseases across several therapeutic areas, including central nervous system (CNS) disorders, lysosomal storage disorders (LSDs), metabolic disorders, and other diseases that can be targeted through protein degradation, such as oncology. The Company's clinical stage product candidate, GT-02287, is being developed for the treatment of Parkinson's disease with and without GBA1 mutations. The Company generated an extensive preclinical data package providing evidence of the mechanism of action.

Gain Therapeutics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	21
Exchange	NASDAQ
Company Website	https://www.gaintherapeutics.com

How to Buy Gain Therapeutics, Inc. (GANX) Stock on MEXC

Eligible investors can buy real shares of Gain Therapeutics, Inc. (GANX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for GANX and Place Your Order

Open the RealStocks trading page and search for GANX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Gain Therapeutics, Inc. (GANX) stock price today?

Gain Therapeutics, Inc. (GANX) is currently trading at $ 1.83, up 1.39% ($0.02) from the previous close of $ 1.80. Intraday prices update in real time during regular trading hours.

2.Is GANX stock going up or down today?

As of 2026-09-08 23:31:00, GANX is trading at $ 1.83, up 1.39% ($0.02) from its previous close of $ 1.80. The stock has traded between $ 0.89 and $ 17.93 during today’s regular session. Past price movements do not guarantee future results.

3.What is GANX pre-market price?

As of 2026-09-08 23:31:00, GANX is trading at $ 1.82 in pre-market trading, up 0.83% ($0.01) from the previous close of $ 1.80. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is GANX after-hours price?

As of 2026-09-08 23:31:00, GANX is trading at $ 1.84 in after-hours trading, up 2.44% ($0.04) from the regular-session close of $ 1.80. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is GANX stock trading now?

GANX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does GANX sit relative to its 52-week high and low?

Over the past 52 weeks, GANX has traded between a low of $ 1.53 and a high of $ 4.34. At $ 1.83, the stock is positioned 10.5% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Gain Therapeutics, Inc. in?

Gain Therapeutics, Inc. (GANX) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Gain Therapeutics, Inc.'s market capitalisation and where is it listed?

Gain Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 78.56M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is GANX valued in terms of P/E ratio and EPS?

GANX trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Gain Therapeutics, Inc. pay a dividend?

Gain Therapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.